Haffkine Bio-Pharma hopeful of Covaxin production in 8 months, targets 22.8 crore doses a year

Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisite facilities are in place.

Haffkine Bio-Pharmaceutical Corporation Limited (HBPCL), a Maharashtra government undertaking, is preparing for mass production of Covaxin and will have capacity to produce over 22 crore doses of the COVID-19 vaccine every year once the requisite facilities are in place. June 02, 2021 at 12:30PM https://ift.tt/3uLuk3I